Published in N Engl J Med on August 23, 2001
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail (2009) 1.93
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail (2015) 1.40
Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail (2008) 1.31
A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure. Am J Cardiol (2009) 1.24
The cardiorenal syndrome: a review. Int J Nephrol (2010) 1.00
Decongestion in acute heart failure. Eur J Heart Fail (2014) 0.94
Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev (2011) 0.92
Chronic heart failure in older adults. Med Clin North Am (2011) 0.90
Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis. Heart Fail Rev (2012) 0.87
DEFEAT heart failure: assessment and management of heart failure in nursing homes made easy. J Am Med Dir Assoc (2008) 0.84
Central venous pulse pressure analysis using an R-synchronized pressure measurement system. J Clin Monit Comput (2006) 0.84
Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail Rev (2012) 0.83
Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One (2014) 0.82
Cardiorenal syndrome in acute heart failure syndromes. Int J Nephrol (2011) 0.82
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med (2014) 0.82
Cardiorenal syndrome: an unsolved clinical problem. Int J Nephrol (2011) 0.81
Acute lung failure. Semin Respir Crit Care Med (2011) 0.81
Emerging therapies for heart failure: renal mechanisms and effects. Heart Fail Rev (2012) 0.81
Cardiorenal syndrome caused by heart failure with preserved ejection fraction. Int J Nephrol (2011) 0.80
Threshold crossing of device-based intrathoracic impedance trends identifies relatively increased mortality risk. Eur Heart J (2012) 0.79
Why Current Doppler Ultrasound Methodology Is Inaccurate in Assessing Cerebral Venous Return: The Alternative of the Ultrasonic Jugular Venous Pulse. Behav Neurol (2016) 0.78
Renal dysfunction in acute heart failure. Korean Circ J (2011) 0.78
Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure. Clin Res Cardiol (2009) 0.78
Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arq Bras Cardiol (2014) 0.78
Prognostic implication of physical signs of congestion in acute heart failure patients and its association with steady-state biomarker levels. PLoS One (2014) 0.77
Pathophysiology and clinical evaluation of acute heart failure. Nat Rev Cardiol (2015) 0.77
Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol (2016) 0.77
The Oscillating Component of the Internal Jugular Vein Flow: The Overlooked Element of Cerebral Circulation. Behav Neurol (2015) 0.77
Meta-Analysis of Ultrafiltration versus Diuretics Treatment Option for Overload Volume Reduction in Patients with Acute Decompensated Heart Failure. Arq Bras Cardiol (2015) 0.76
The jugular venous pulse and third heart sound in patients with heart failure. N Engl J Med (2001) 0.76
Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure. Trans Am Clin Climatol Assoc (2009) 0.76
DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians. Minerva Med (2009) 0.75
Central Venous Pressure Monitoring; Introduction of a New Device. Emerg (Tehran) (2016) 0.75
Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements. Wien Klin Wochenschr (2016) 0.75
Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. Clin Biochem (2017) 0.75
Clinical and Prognostic Significance of Positive Hepatojugular Reflux on Discharge in Acute Heart Failure: Insights from the ESCAPE Trial. Biomed Res Int (2017) 0.75
Hypothyroidism and renal function in patients with systolic heart failure. Tex Heart Inst J (2010) 0.75
Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study. J R Soc Med (2016) 0.75
A case of tricuspid regurgitation and congestive cardiac failure presenting with orbital pulsation. JRSM Cardiovasc Dis (2012) 0.75
A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjects. BMC Pharmacol Toxicol (2014) 0.75
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 0.75
The role of ultrafiltration in patients with decompensated heart failure. Int J Nephrol (2010) 0.75
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med (2001) 0.75
Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment. Curr Heart Fail Rep (2017) 0.75
Novel Endpoints for Heart Failure Clinical Trials. Curr Heart Fail Rep (2017) 0.75
Inferior vena cava diameter in acute decompensated heart failure as predictor of all-cause mortality. Heart Vessels (2017) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med (2001) 5.30
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol (2000) 2.99
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation (1999) 2.39
Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med (1997) 2.39
Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol (1997) 2.35
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation (2000) 2.22
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J (2000) 1.94
The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J (1999) 1.94
Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant (2001) 1.92
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J (1999) 1.90
Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest (1988) 1.76
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol (1998) 1.70
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation (1989) 1.61
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J (2001) 1.55
Quality of life in patients with advanced heart failure. J Heart Lung Transplant (1992) 1.47
Comparison of thermodilution and transthoracic electrical bioimpedance cardiac outputs. Heart Lung (1991) 1.47
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation (1997) 1.46
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol (1993) 1.39
Inotropic therapy for heart failure. N Engl J Med (1998) 1.39
Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol (1995) 1.29
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol (2001) 1.26
Incidence and significance of early pericardial effusions after cardiac surgery. Am J Cardiol (1984) 1.26
Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest (1990) 1.25
Sudden death prevention in patients with advanced ventricular dysfunction. Circulation (1993) 1.23
Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant (1999) 1.23
Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol (1993) 1.20
Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol (1994) 1.19
Timing of sudden death in patients with heart failure. J Am Coll Cardiol (1994) 1.19
Recipient-to-donor atrioatrial conduction after orthotopic heart transplantation: surface electrocardiographic features and estimated prevalence. Am J Cardiol (1998) 1.12
Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 1.06
Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol (1990) 1.05
Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J (2001) 1.03
Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol (1996) 1.03
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol (1992) 1.02
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors. Am Heart J (2000) 1.02
24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol (1993) 1.01
Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation (1986) 1.01
Reversal of ischemic myocardial dysfunction by PTCA in a cardiac transplant patient. Am Heart J (1986) 1.00
Heart transplantation in a Jehovah's Witness. J Heart Transplant (1987) 1.00
Sexual function in patients with advanced heart failure. Heart Lung (1996) 1.00
Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. Am J Cardiol (1987) 0.97
Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J (1993) 0.96
Beta-adrenergic blockers and survival in heart failure. N Engl J Med (1996) 0.94
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol (1999) 0.93
Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1993) 0.93
Atrial fibrillation in heart failure. N Engl J Med (1999) 0.92
The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size. J Am Coll Cardiol (1998) 0.91
Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation (1994) 0.90
Extended comparison of quality of life between stable heart failure patients and heart transplant recipients. J Heart Lung Transplant (1995) 0.89
Excessive oxygen deficit during low-level exercise in heart failure. Am J Cardiol (1995) 0.88
Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation (1991) 0.85
Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol (2001) 0.85
Effect of intensive therapy for heart failure on the vasodilator response to exercise. J Am Coll Cardiol (1999) 0.84
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. J Am Coll Cardiol (2001) 0.84
Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J (1988) 0.83
Amiodarone and torsades de pointes in patients with advanced heart failure. Am J Cardiol (1995) 0.82
Report of the consensus conference on candidate selection for Heart Transplantation-1993. J Heart Lung Transplant (1995) 0.82
Orthotopic heart transplantation and concurrent coronary bypass. J Heart Lung Transplant (1993) 0.82
Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J Am Coll Cardiol (1991) 0.81
Effect of tricuspid regurgitation on the reliability of the thermodilution cardiac output technique in congestive heart failure. Am J Cardiol (1989) 0.81
Thyroid hormone abnormalities in heart failure: possibilities for therapy. Thyroid (1996) 0.81
Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure. Am J Crit Care (1997) 0.80
Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Circulation (1990) 0.80
Postdefibrillation idioventricular rhythm--a salvageable condition. West J Med (1987) 0.80
Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure. Am J Cardiol (1990) 0.80
Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplants during and after successful treatment of rejection. Circulation (1994) 0.80
Late potentials are unaltered by ventricular filling pressure reduction in heart failure. Am Heart J (1991) 0.79
Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group. Circulation (1996) 0.79
Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J (1995) 0.78
Antibodies to the T-cell receptor (CD3) induce LFA-1/Mac-1-dependent mononuclear cell adhesion to human arterial endothelium. J Heart Lung Transplant (1994) 0.78
Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death. Am J Cardiol (1990) 0.78
Take heart with heart failure. Circulation (2001) 0.78
Mechanical cardiac support 2000: current applications and future trial design. J Heart Lung Transplant (2001) 0.77
Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am J Cardiol (1991) 0.77
Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland. Circulation (2001) 0.77
Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism. Clin Cardiol (2001) 0.77
Mitral regurgitation after cardiac transplantation. Am J Cardiol (1987) 0.77
Diastolic heart failure: miles to go before we sleep. Am J Med (2000) 0.77
Destination mechanical circulatory support: proposal for clinical standards. J Heart Lung Transplant (2003) 0.76
Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure. J Heart Lung Transplant (2000) 0.76
Acute reversible cardiogenic shock: immune-mediated with mild histologic change. Am Heart J (1986) 0.76
Cardiac transplantation. Selection, immunosuppression, and survival. West J Med (1988) 0.76
Toward an improved understanding and management of human heart transplant recipients. J Am Coll Cardiol (1992) 0.76
Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits. J Heart Lung Transplant (1996) 0.76
Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure. Am Heart J (1992) 0.75
Rites and responsibility for resuscitation in heart failure: tread gently on the thin places. Circulation (1998) 0.75
Endothelin and the vascular choir in heart failure. J Am Coll Cardiol (1992) 0.75
Heart transplant centers: no longer the end of the road for heart failure. J Am Coll Cardiol (1996) 0.75
Recipient mononuclear cell recognition and adhesion to graft endothelium after human cardiac transplantation. Lymphocyte recognition leads to monocyte adhesion. J Clin Invest (1994) 0.75
Brain natriuretic peptide as bridge to therapy for heart failure. Lancet (2000) 0.75
The jugular veins: knowing enough to look. Am Heart J (1998) 0.75
Randomized study of high dose oral cyclosporine therapy for mild acute cardiac rejection. J Heart Transplant (1989) 0.75